Using Data-Dependent and -Independent Hybrid Acquisitions for Fast Liquid Chromatography-Based Untargeted Lipidomics by Kanako Tokiyoshi (17736114)

“…The workflow is demonstrated using an 8.6 min LC gradient, where the QC samples are analyzed using five different SWATH-DIA methods. The use of both DDA and SWATH-DIA achieves a 1.7-fold annotation coverage from publicly available benchmark data obtained using a fast LC-DDA-MS technique and offers 95.3% lipid coverage, as compared to the benchmark data set from a 25 min LC gradient. …”

Using Data-Dependent and -Independent Hybrid Acquisitions for Fast Liquid Chromatography-Based Untargeted Lipidomics by Kanako Tokiyoshi (17736114)

“…The workflow is demonstrated using an 8.6 min LC gradient, where the QC samples are analyzed using five different SWATH-DIA methods. The use of both DDA and SWATH-DIA achieves a 1.7-fold annotation coverage from publicly available benchmark data obtained using a fast LC-DDA-MS technique and offers 95.3% lipid coverage, as compared to the benchmark data set from a 25 min LC gradient. …”

Using Data-Dependent and -Independent Hybrid Acquisitions for Fast Liquid Chromatography-Based Untargeted Lipidomics by Kanako Tokiyoshi (17736114)

“…The workflow is demonstrated using an 8.6 min LC gradient, where the QC samples are analyzed using five different SWATH-DIA methods. The use of both DDA and SWATH-DIA achieves a 1.7-fold annotation coverage from publicly available benchmark data obtained using a fast LC-DDA-MS technique and offers 95.3% lipid coverage, as compared to the benchmark data set from a 25 min LC gradient. …”

Using Data-Dependent and -Independent Hybrid Acquisitions for Fast Liquid Chromatography-Based Untargeted Lipidomics by Kanako Tokiyoshi (17736114)

“…The workflow is demonstrated using an 8.6 min LC gradient, where the QC samples are analyzed using five different SWATH-DIA methods. The use of both DDA and SWATH-DIA achieves a 1.7-fold annotation coverage from publicly available benchmark data obtained using a fast LC-DDA-MS technique and offers 95.3% lipid coverage, as compared to the benchmark data set from a 25 min LC gradient. …”

Image_5_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif by Ozair Abawi (8816267)

“…Mean REE% was higher in children with non-syndromic genetic obesity (107.4% ± 12.7) and lower in children with hypothalamic obesity (87.6% ± 14.2) compared to multifactorial obesity (100.5% ± 12.6, both p<0.01). In 9 children with pseudohypoparathyroidism type 1a, mean REE% was similar (100.4 ± 5.1). …”

A <i>pals-5p</i>::<i>GFP</i> fusion gene is induced in synMuv B mutants in the absence of viral infection. by Ashwin Seetharaman (615458)

Comparison of regression fits of annual growth rate (%) as a function of the D5+/D20+ ratio (solid line) and P index (dashed line). by Patrik Galeta (16015459)

cMSC/Collagen Type I gel fabrication. by Melissa A. MacIver (12850566)

Subjects:

Transcriptional analysis of chondrogenic and osteogenic genes. by Melissa A. MacIver (12850566)

Subjects:

Toluidine blue histology of cMSC constructs for initial chondrogenic screening. by Melissa A. MacIver (12850566)

Subjects:

Immunofluorescence of select extracellular matrix (ECM) components. by Melissa A. MacIver (12850566)

Subjects:

Characterization of passage 1 (P1) bone marrow-derived canine mesenchymal stromal cells (cMSCs). by Melissa A. MacIver (12850566)

Subjects:

TUNEL staining. by Melissa A. MacIver (12850566)

Subjects:

Safranin O and toluidine blue histology. by Melissa A. MacIver (12850566)

Subjects:

Experimental outline. by Melissa A. MacIver (12850566)

Subjects:

Cytotoxicity and total glycosaminoglycan (GAG) content. by Melissa A. MacIver (12850566)

Subjects:

Gross photography and construct weight for initial chondrogenic screening. by Melissa A. MacIver (12850566)

Subjects:

Delayed boost increases IgG4 and IgA1. by LaTonya D. Williams (3140490)

Table5_Reasons that lead people to buy prescription medicines on the internet: a systematic review.docx by Hamzeh Almomani (14486128)

Image_2_Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses—A Proof-of-Principle Study.pdf by Sandra Tamulyte (5421065)

“…</p><p>Results: Depending on the HLA-DR threshold applied for stratification (≤8,000/≤5,000/≤2,000 molecules/cell), a large group of patients (85.5/68.2/40.0%) already presented with a robust decrease of HLA-DR on admission, independent of the cause for critical illness. …”